<PAGE>
__________________________________________________________________
__________________________________________________________________
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934 FOR THE
QUARTERLY PERIOD ENDED SEPTEMBER 30, 1997
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE
TRANSITION PERIOD FROM __________ TO ___________
Commission File Number 0-26516
EUPHONIX, INC.
(Exact name of registrant as specified in its charter)
California 77-0189481
---------- ----------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
220 Portage Avenue, Palo Alto, CA 94306
---------------------------------------
(Address of principal executives, zip code)
(650) 855-0400
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant has filed (1) all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
Yes X No
--------- ---------
The number of shares outstanding of the registrant's common stock as of Septem-
ber 30, 1997 was 5,587,142 ($.001 par value).
<PAGE>
EUPHONIX, INC.
FORM 10-Q
TABLE OF CONTENTS
Page
PART I. FINANCIAL INFORMATION
ITEM 1. Condensed Consolidated Financial Statements (Unaudited):
Condensed Consolidated Statements of Operations for the
three and nine months ended September 30, 1997 and 1996..................3
Condensed Consolidated Balance Sheets as of
September 30, 1997 and December 31, 1996.................................4
Condensed Consolidated Statements of Cash Flows
for the nine months ended September 30, 1997 and 1996....................5
Notes to Condensed Consolidated Financial Statements.......................6
ITEM 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations.......................................8
PART II. OTHER INFORMATION
ITEM 6. Exhibits and Reports on Form 8-K..................................12
Signature.................................................................13
Page 2 of 14
<PAGE>
PART I. FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
Euphonix, Inc.
Condensed Consolidated Statements of Operations
(unaudited)
<TABLE>
<CAPTION
Three Months Ended Nine Months Ended
September 30, September 30,
1997 1996 1997 1996
-------- -------- -------- --------
<S> <C>
Nets revenues..............$ 3,754,347 $ 3,561,606 $ 13,198,284 $ 14,104,716
Cost of sales.............. 1,754,771 1,861,992 6,664,670 6,753,385
--------- --------- ---------- ----------
Gross profit............... 1,999,576 1,699,614 6,533,614 7,351,331
Operating expenses:
Research & development... 1,037,465 666,565 2,853,144 1,907,576
In-process technology.... ---- ---- ---- 1,445,839
Sales & marketing........ 1,458,775 1,188,718 3,964,442 3,334,189
General & administrative. 355,055 370,966 1,575,171 1,415,612
--------- --------- ---------- ----------
Total operating expenses... 2,851,295 2,226,249 8,392,757 8,103,216
--------- --------- ---------- ----------
Operating loss............. (851,719) (526,635) (1,859,143) (751,885)
Other income (loss)........ (15,688) 96,135 145,426 348,307
---------- --------- ---------- ----------
Loss before income taxes... (867,407) (430,500) (1,713,717) (403,578)
Provision (benefit) for
income taxes...... (110,060) (133,000) (110,060) 323,706
--------- --------- ---------- ----------
Net loss...................$ (757,347) $ (297,500) $(1,603,657) $ (727,284)
========= ========= ========== ==========
Loss per share ............$ (0.14) $ (0.05) $ (0.29) $ (0.13)
========= ========= ========== ==========
Number of shares used in
computing per share amounts
(in thousands).............. 5,577 5,544 5,571 5,500
========= ========= ========== ==========
</TABLE>
See accompanying notes
Page 3 of 14
<PAGE>
Euphonix, Inc.
Condensed Consolidated Balance Sheets
<TABLE>
<CAPTION> September 30, December 31,
1997 1996
------------- ------------
<S> <C> (unaudited) (note)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents................ $ 1,063,225 $ 1,428,095
Short-term investments................... 2,553,631 5,591,272
Accounts receivable,net.................. 2,178,555 1,626,756
Inventories.............................. 6,674,900 4,674,082
Prepaid expenses and other current assets 827,449 697,064
------------- -------------
Total current assets....................... 13,297,760 14,017,269
Property and equipment, net................ 1,318,797 1,247,933
Deposits and other assets.................. 185,854 200,561
------------- -------------
Total assets............................... $ 14,802,411 $ 15,465,763
============= =============
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Short term borrowings.................... $ 500,000 $ ----
Accounts payable......................... 1,664,845 736,939
Accrued payroll and related liabilities,
including deferred salary............... 433,381 515,786
Accrued warranty......................... 413,956 382,715
Accrued commissions...................... 162,245 251,958
Income taxes payable..................... ---- 50,892
Other accrued liabilities................ 200,200 515,680
Customer deposits........................ 390,199 484,960
Short term portion capital leases........ 9,958 43,679
------------- --------------
Total current liabilities.................. 3,774,784 2,982,609
Long term portion capital leases........... 65,948 65,948
Deferred rent.............................. 3,698 5,284
Deferred income taxes...................... 74,000 74,000
COMMITMENTS
SHAREHOLDERS' EQUITY:
Preferred stock, $0.001 par value: 2,000,000
authorized shares, none issued and outstanding ---- ----
Common stock, $0.001 par value:
20,000,000 authorized shares, 5,587,142 and
5,565,288 shares issued and outstanding in
1997 and 1996, respectively............... 5,587 5,566
Additional paid-in capital................. 13,722,401 13,719,069
Accumulated deficit........................ (2,760,870) (1,157,213)
Equity adjustment from foreign currency
translation............................... 78,863 ----
Deferred compensation...................... (162,000) (229,500)
-------------- ---------------
Total shareholders' equity.................. 10,883,981 12,337,922
-------------- ---------------
Total liabilities and shareholders' equity.. $ 14,802,411 $ 15,465,763
============== ===============
</TABLE>
Note: The balance sheet at December 31, 1996 has been derived from the audited
financial statements at that date. See notes to condensed financial statements.
See accompanying notes
Page 4 of 14
<PAGE>
Euphonix, Inc.
Condensed Consolidated Statements of Cash Flows
<TABLE> (unaudited)
<CAPTION>
Nine Months Ended
September 30,
1997 1996
<S> <C> ------------ --------------
Operating activities
Net loss.................................$ (1,603,657) $ (727,284)
Adjustments to reconcile net loss to net
cash used in operating activities:
Depreciation............................ 278,788 138,688
Amortization of organization expense.... 2,333 ----
Amortization of patents, trademarks, and
copyrights............................. 12,374 ----
Amortization of technology and goodwill. ---- 153,512
Deferred compensation amortization...... 67,500 67,500
Acquired research and development....... ---- 1,445,838
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
and other assets....................... (130,385) (682,534)
Accounts receivable..................... (551,799) (314,482)
Inventories............................. (1,921,954) (1,726,606)
Accounts payable, accrued liabilities,
and deferred rent...................... 419,071 315,123
Customer deposits....................... (94,761) (2,150,465)
-------------- -------------
Total adjustments......................... (1,918,833) (2,753,426)
-------------- -------------
Net cash used in operating activities..... (3,522,490) (3,480,710)
Investing activities
Purchase of Spectral, Inc. net of cash
acquired................................. ---- (2,283,327)
Proceeds from sales of short-term investment
maturities............................... 4,082,530 5,388,669
Purchases of short-term investments....... (1,044,889) ----
Purchase of property and equipment........ (349,653) (319,593)
------------- --------------
Net cash provided by investing activities. 2,687,988 2,785,749
Financing activities
Principal payments under capital lease
obligations.............................. (33,721) (25,999)
Proceeds from sale of common stock........ 3,353 239,881
Proceeds from short term bank borrowings.. 500,000 ----
------------- ---------------
Net cash provided by financing activities. 469,632 213,882
Net decrease in cash and cash equivalents. (364,870) (481,079)
Cash and cash equivalents at beginning of
period................................... 1,428,095 860,527
------------ --------------
Cash and cash equivalents at end of
period...................................$ 1,063,225 $ 379,448
============ ==============
Supplemental disclosures of cash flow
information
Cash paid for income taxes................$ ---- $ 754,000
See accompanying notes
</TABLE>
Page 5 of 14
<PAGE>
EUPHONIX, INC.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have
been prepared in accordance with generally accepted accounting principles for
interim financial information and with the instructions to Form 10-Q and article
10 of Regulation S-X. Accordingly, they do not include all of the information
and footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments (consisting
only of normal recurring adjustments) considered necessary for a fair presenta-
tion have been included. Operating results for the nine-month period ended Sep-
tember 30, 1997 are not necessarily indicative of the results that may be
expected for the entire year ending December 31, 1997.
For further information, refer to the audited financial statements and
footnotes thereto included in the Registrant Company's annual report on Form
10-K for the year ended December 31, 1996.
2. Business Activities
Euphonix, Inc. (the "Company") was incorporated on July 6, 1988. The
Company's core business is the development, manufacture and marketing of dig-
itally controlled audio mixing consoles and accessories for use in the produc-
tion of audio content for music, post production for film and television,
broadcast, live sound reinforcement and multimedia world-wide markets. On
February 7, 1996, Euphonix acquired 100% of the stock of Spectral Incorporated.
Spectral, a wholly owned subsidiary, develops and markets PC-based digital audio
workstations. On March 1, 1997, Euphonix, Japan, a wholly owned subsidiary
began operations. Euphonix, Japan will include sales and marketing, customer
service, technical support and finance functions.
3. Net Loss per share
Net loss per share is based upon the weighted average number of common
stock outstanding during the period. Common equivalent shares from options
have been included in the computation when dilutive.
In February 1997, the Financial Accounting Standards Board Issued State-
ment No. 128, Earnings per Share, which is required to be adopted on December
31, 1997. At that time, the Company will be required to change the method cur-
rently used to compute earnings per share and to restate all prior periods.
Under the new requirements for calculating primary earnings per share, the
dilutive effect of stock options will be excluded. The impact on primary and
fully diluted earnings per share for the third quarter and nine months ended
September 30, 1997 and September 30, 1996 is not expected to be material.
Page 6 of 14
<PAGE>
EUPHONIX, INC.
Notes to Condensed Consolidated Financial Statements - Continued
4. Inventories
Inventories are stated at the lower cost (first-in, first-out) or market
(net realizable value). Inventories consist of the following:
<TABLE>
<CAPTION>
September 30, December 31,
1997 1996
------------- ------------
<S> <C>
Raw materials........................ $ 1,911,081 $ 1,983,382
Work-in-process...................... 1,563,008 935,211
Finished goods....................... 3,200,811 1,755,489
------------- ------------
$ 6,674,900 $ 4,674,082
============= ============
</TABLE>
5. Income Taxes
The Company's benefit for income taxes for the nine months ended September
30, 1997 is based on the Company's estimate of the annual effective tax rate
for 1997. The Company's effective tax rate for the nine months ended September
30, 1997 was 13%. The Company's effective tax rate was 31% in 1996, before the
effect of certain non-deductible merger related charges. The effective tax rate
for the third quarter of 1997 differs from the federal statutory rate due to the
limitations on recognition of deferred tax assets imposed by "Statement of
Financial Accounting Standards ("SFAS") 109, Accounting for Income Taxes".
The effective tax rate for the third quarter of 1996 differs from the federal
statutory rate of 34% primarily due to the recognition of certain deferred tax
assets based on available carry-back potential.
6. Preferred Stock
In July 1995, the Board of Directors amended, and the shareholders subse-
quently approved, the Company's Articles of Incorporation to authorize 2,000,000
shares of undesignated preferred stock. Preferred stock may be issued from time
to time in one or more series. The Board of Directors is authorized to deter-
mine the rights, preferences, privileges, and restrictions granted to and
imposed upon any wholly unissued series of preferred stock and to fix the num-
ber of shares of any series of preferred stock and the designation of any such
series without any vote or action by the Company's shareholders.
Page 7 of 14
<PAGE>
Item 2. Management's Discussion & Analysis of Financial Condition & Results of
Operations.
This Quarterly Report on Form 10-Q contains forward-looking statements
that involve risks and uncertainties. The Company's actual results may differ
significantly from the results discussed in the forward-looking statements.
Factors that might cause such a difference include, but are not limited to,
those discussed in the section entitled "Factors Affecting Future Operating
Results."
Results of Operations
Net Revenues. Net revenues were $3.8 million for the third quarter of
1997, which was 5.4% above third quarter 1996 revenues of $3.6 million. For the
first nine months of fiscal 1997, net revenues of $13.2 million decreased 6.4%
from $14.1 million from the first nine months of 1996. The Company's decrease in
net revenues for the first nine months of 1997, resulted primarily from reduced
European sales. Substantially all sales are denominated in United States dollars
to reduce the effect of fluctuations in foreign currency exchange rates.
Domestic sales of the Company's products for the third quarter of 1997 and
1996 were $2.0 million and $1.7 million, respectively, comprising approximately
53.5% and 47.7% of the Company's net revenues for the third quarter of 1997 and
1996, respectively. Domestic sales were $7.8 million and $6.5 million compris-
ing approximately 59.1% and 46.1% of the Company's net revenues for the first
nine months of 1997 and 1996, respectively. Export sales were $1.7 million and
$1.9 million comprising approximately 46.5% and 52.3% of the Company's revenues
for the third quarter of 1997 and 1996, respectively. Export sales were $5.4
million and $7.6 million comprising approximately 40.9% and 53.9% of the Com-
pany's revenues for the first nine months of 1997 and 1996, respectively. The
Company believes that export sales as a percent of net revenues decreased in the
first nine months of 1997 due to fewer sales in European countries, as compared
to the first nine months of 1996.
Gross Margin. The Company's gross margin of $2.0 million increased to
53.3% in the third quarter of 1997, up from $1.7 million or 47.7% in 1996. For
the first nine months of fiscal 1997, gross margin was $6.5 million, or 49.5% of
net revenues, compared with $7.4 million , or 52.1% of net revenues, for the
first nine months of fiscal 1996. The increase in the third quarter of 1997 from
the third quarter of 1996 was primarily attributable to lower overhead type
expenses. The decrease in the first nine months of 1997 from the first nine
months of 1996 was primarily due to production costs related to the introduc-
tion of the Company's new CS3000 mixing consoles. Margins are expected to
increase going forward as the Company gains efficiencies through volume produc-
tion of the new product.
Research and Development Expenses. Research and development expenses
increased to $1.0 million in the third quarter of 1997, up from $667,000 in
the third quarter of 1996, representing an increase of 55.6% in 1997. For the
first nine months in 1997, research and development expenses of $2.9 million
increased 49.6% from $1.9 million in 1996. Research and development expenses
constituted 27.6%, 18.7%, 21.6%, and 13.5% of net revenues in the third quarter
of 1997 and 1996 and the first nine months of 1997 and 1996, respectively. The
increases resulted primarily from new product development costs primarily
related to next generation products, and additional personnel.
Page 8 of 14
<PAGE>
Sales and Marketing Expenses. Sales and marketing expenses increased to
$1.5 million in the third quarter of 1997, from $1.2 million in the third quar-
ter of 1996, representing an increase of 22.7%. For the first nine months of
fiscal 1997, sales and marketing expenses of $4.0 million increased 18.9% from
$3.3 million in 1996. Sales and marketing expenses constituted 38.9%, 33.4%,
30%, and 23.6% of net revenues in the third quarter of 1997 and 1996 and the
first nine months of 1997 and 1996, respectively. The increases resulted pri-
marily from investment in targeting new markets and expanding the Company's
international sales and marketing presence in established, and new territories
through increased advertising, trade shows, and product demonstrations.
General and Administrative Expenses. General and administrative expenses
decreased to $355,000 in the third quarter of 1997 from $371,000 in the third
quarter of 1996, representing a decrease of 4.3%. For the first nine months of
fiscal 1997, general and administrative expenses of $1.6 million increased 11.3%
from $1.4 million in the first nine months of 1996. General and administrative
expenses constituted 9.5%, 10.4%, 11.9%, and 10% of net revenues in the third
quarter of fiscal 1997 and 1996 and the first nine months of fiscal 1997 and
1996, respectively. The increase in the first nine months was mostly attribut-
able to an increase in bad debt reserves. The decrease from the third quarter
of 1996 to the third quarter of 1997 was attributable to a decrease in person-
nel costs.
Provision for Income Taxes. The Company's effective tax rate is a benefit
of 13% in 1997. The Company's effective tax rate was 31% in 1996, before the
effect of certain non-deductible merger related charges. The effective tax rate
for the third quarter of 1997 and 1996 differs from the federal statutory rate
of 34% primarily due to limitations on the recognition of deferred tax assets
imposed by SFAS 109, "Accounting for Income Taxes." The Company expects that its
effective tax rate will be higher in future years as the amount of unrecognized
deferred tax assets is reduced.
Liquidity and Capital Resources
The Company has funded its operations to date primarily through cash flows
from operations, the private sale of equity securities, and the initial public
offering of Common Stock completed in September 1995, which generated net pro-
ceeds of approximately $9.3 million. For the nine months ended September 30,
1997, cash, cash equivalents and short-term investments decreased by $3.4 mil-
lion to approximately $3.6 million, mainly due to the operating cash require-
ments of Spectral Incorporated, and lower than anticipated sales in general.
Also, during this period, working capital decreased by $1.5 million to approx-
imately $9.5 million.
The Company's operating activities used cash of approximately $3.6 million
and $3.5 million for the nine months ended September 30, 1997 and 1996, respec-
tively. Cash used in operating activities for 1997 was comprised primarily of
net loss, an increase in inventory and accounts receivable, an increase in pre-
paid expenses, other current assets and other assets, a decrease in customer
deposits, offset partially by an increase in accounts payable and other accrued
liabilities. Cash used in operating activities for 1996 was comprised primarily
of net loss, a decrease in customer deposits, an increase in inventory, an
increase in accounts receivable, an increase in prepaid expenses and other cur-
rent assets and other assets, offset partially by an increase in accounts pay-
able and other accrued liabilities, and non cash items including acquired in-
process research and development.
As of September 30, 1997, the Company's sources of liquidity included cash,
cash equivalents and short-term investments totaling approximately $3.6 million,
and an unsecured bank line of credit of up to $500,000. As of September 30,
1997, $500,000 of borrowings were outstanding under such line of credit and
the Company was in compliance with debt covenants.
Page 9 of 14
<PAGE>
Factors Affecting Future Operating Results
The Company has derived virtually all of its revenues from sales of its
digitally controlled audio mixing console system, which system is based upon its
proprietary software and hardware platform. The Company believes that sales of
this system, along with enhancements thereof, will continue to constitute
virtually all of the Company's revenues for the foreseeable future, notwith-
standing sale of digital audio workstations sold by Spectral. Accordingly, any
factor adversely affecting the Company's base system, whether technical, com-
petitive or otherwise, could have a material adverse effect on the Company's
business and results of operations.
A limited number of the Company's system sales typically account for a sub-
stantial percentage of the Company's quarterly revenue because of the relatively
high average sales price of such systems. Moreover, the Company's expense levels
are based in part on its expectations of future revenue. Therefore, if revenue
is below expectations, the Company's operating results are likely to be adverse-
ly affected. In addition, the timing of revenue is influenced by a number of
other factors, including the timing of individual orders and shipments, indus-
try trade shows, seasonal customer buying patterns, changes in product develop-
ment and sales and marketing expenditures, custom financing arrangements,
production limitations and international sales activity. Because the Company's
operating expenses are based on anticipated revenue levels and a high percentage
of the Company's expenses are relatively fixed in the short term, variations in
the timing of recognition of revenue could cause significant fluctuations in
operating results from quarter to quarter and may result in unanticipated quar-
terly earnings shortfalls or losses.
The markets for the Company's system are characterized by changing tech-
nologies and new product introductions. The Company's future success will
depend in part upon its continued ability to enhance its base system with
features, including new software and hardware add-ons, and to develop or
acquire and introduce new products and features which meet new market demands
and changing customer requirements on a timely basis. In addition, there can be
no assurance that products or technologies developed by others will not render
the Company's products or technologies non-competitive or obsolete.
To date, the Company's primary market success has been in the music segment
of the professional audio market. In order for the Company to grow, the Company
believes that it must continue to gain market share in the music market segment,
as well as in its other targeted market segments. There can be no assurance
that the Company will be able to compete favorably in any other market segments.
The Company's inability to compete favorably could have a material adverse
effect on its business and results of operations. The markets for the Company's
products are intensely competitive and characterized by significant price compe-
tition. The Company believes that its ability to compete depends on elements
both within and outside its control, including the success and timing of new
product development and introduction by the Company and its competitors, product
performance and price, distribution, availability of lease or other financing
alternatives, resale of used systems and customer support.
Currently, the Company uses many sole or limited source suppliers, certain
of which are critical to the integrated circuits included in the Company's base
system. Major delays or terminations in supplies of such components could have
a significant adverse effect on the Company's timely shipment of its products,
which in turn would adversely affect the Company's business and results of
operations. The Company also relies on single vendors to manufacture major sub-
assemblies for its products. Any extended interruption in the future supply or
Page 10 of 14
<PAGE>
increase in the cost of subassemblies manufactured by its primary or other third
party vendors could have a material adverse effect on the Company's business and
results of operations.
In addition, as different electrical, radiation or other standards applic-
able to the Company's products are adopted in countries, including the United
States, or groups of countries in which the Company sells its products, the
failure of the Company to modify its products, if necessary, to comply with
such standards would likely have an adverse effect on the Company's business and
results of operations.
The Company generally relies on a combination of trade secret, copyright
law and trademark law, contracts and technical measures to establish and protect
its proprietary rights in its products and technologies. However, the Company
believes that such measures provide only limited protection of its proprietary
information, and there is no assurance that such measures will be adequate to
prevent misappropriation. In addition, significant and protracted litigation may
be necessary to protect the Company's intellectual property rights, to determine
the scope of the proprietary rights of others or to defend against claims of
infringement. There can be no assurance that third-party claims alleging
infringement will not be asserted against the Company in the future. Any such
claims could have a material adverse effect on the Company's business and
results of operations.
The Company's success depends, in part, on its ability to retain key
management and technical employees and its continued ability to attract and
retain highly skilled personnel. In addition, the Company's ability to manage
any growth will require it to continue to improve and expand its management,
operational and financial systems and controls. If the Company's management is
unable to manage growth effectively, its business and results of operations
will be adversely affected.
As a result of these and other factors, the Company has experienced signi-
ficant quarterly fluctuations in operating results and anticipates that these
fluctuations will continue in future periods. There can be no assurance that the
Company will be successful in maintaining or improving its profitability or
avoiding losses in any future period. Further, it is likely that in some future
period the Company's net revenues or operating results will be below the expec-
tations of public market securities analysts and investors. In such event, the
price of the Company's Common Stock would likely be materially adversely
affected.
Page 11 of 14
<PAGE>
PART II. OTHER INFORMATION
Item 6: Exhibits and Reports on Form 8-K/A
(a) Exhibits.
Exhibit 11.1 - Statement Regarding Computation of Per Share
Earnings (page 14)
Exhibit 27 - Financial Data Schedule - electronic filing only
The exhibits listed on the accompanying index immediately fol-
lowing the signature page are filed as part of this report.
(b) Reports on Form 8-K
None.
Page 12 of 14
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the under-
signed thereunto duly authorized.
Euphonix, Inc.
Date: November 13, 1997 By: /s/ BARRY L. MARGERUM
----------------- ---------------------
Barry L. Margerum, Chief Executive
Officer, President
Page 13 of 14
<PAGE>
EXHIBIT INDEX
Exhibit
Number Exhibit Title
- ------- -------------
11.1 Calculation of Earnings Per Share
27 Financial Data Schedule
EXHIBIT 11.1 Statement re: Computation of Per Share Earnings (Loss)
<TABLE>
<CAPTION>
Three Months Ended Nine Months Ended
September 30, September 30,
1997 1996 1997 1996
------ ------ ------ ------
<S> <C> (in thousands, except per share data)
Weighted average common shares outstanding 5,577 5,544 5,571 5,500
Common equivalent shares attributable to
convertible preferred stock ............. --- --- --- ---
Common equivalent shares attributable to
the net effect of dilutive stock options
based on the treasury stock method using
average market price..................... --- --- --- ---
Shares related to SAB No. 55, 64 and 83... --- --- --- ---
----- ----- ----- -----
Number of shares used in computing per
share amounts............................ 5,577 5,544 5,571 5,500
===== ===== ===== =====
Net (loss) income.........................$ (757) $ (297) $ (1,604) $ (727)
======== ========= ========= ========
Net (loss) income per share...............$ (0.14) $ (0.05) $ (0.29) $ (0.13)
======== ========= ========= ========
FULLY DILUTED
Weighted average common shares outstanding 5,577 5,544 5,571 5,500
Common equivalents shares attributable to
convertible preferred stock.............. --- --- --- ---
Common equivalent shares attributable to the
net effect of dilutive stock options based
on the treasury stock method using quarter
-end (year-end) price, if higher than
average market price..................... --- --- --- ---
Shares related to SAB No. 55, 64 and 83... --- --- --- ---
----- ----- ----- -----
Number of shares used in computing per
share amounts............................ 5,577 5,544 5,571 5,500
====== ====== ====== ======
Net (loss) income.........................$ (757) $ (297) $ (1,604) $ (727)
======== ========= ========= ========
Net (loss) income per share...............$ (0.14) $ (0.05) $ (0.29) $ (0.13)
======== ========= ========= ========
</TABLE>
Page 14 of 14
<PAGE>
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-END> SEP-30-1997
<CASH> 1,063,225
<SECURITIES> 2,553,631
<RECEIVABLES> 2,178,555
<ALLOWANCES> 0
<INVENTORY> 6,674,900
<CURRENT-ASSETS> 13,297,760
<PP&E> 2,426,419
<DEPRECIATION> 1,107,622
<TOTAL-ASSETS> 14,802,411
<CURRENT-LIABILITIES> 3,774,784
<BONDS> 0
0
<COMMON> 5,587
<OTHER-SE> 10,878,394
<TOTAL-LIABILITY-AND-EQUITY> 14,802,411
<SALES> 13,198,284
<TOTAL-REVENUES> 13,198,284
<CGS> 6,664,670
<TOTAL-COSTS> 8,392,757
<OTHER-EXPENSES> (145,426)
<INCOME-PRETAX> (1,713,717)
<INCOME-TAX> (110,060)
<INCOME-CONTINUING> (1,603,657)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,603,657)
<EPS-PRIMARY> (0.29)
<EPS-DILUTED> (0.29)
</TABLE>
